1800-272-662
Shopping Cart 0
countryflagAU
Login

US Physicalrapy Inc

Healthcare US USPH

79.99USD
-0.58(0.72%)

Last update at 2026-03-10T20:00:00Z

Day Range

79.6281.76
LowHigh

52 Week Range

76.81122.97
LowHigh

Fundamentals

  • Previous Close 80.57
  • Market Cap1434.26M
  • Volume90045
  • P/E Ratio55.64
  • Dividend Yield1.80%
  • EBITDA84.22M
  • Revenue TTM585.23M
  • Revenue Per Share TTM42.75
  • Gross Profit TTM 112.02M
  • Diluted EPS TTM1.72

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 55.57M 73.20M 65.51M 70.91M 60.21M
Minority interest -11.24900M -17.09300M 17.30M 17.22M 13.97M
Net income 43.41M 57.92M 52.49M 57.26M 10.10M
Selling general administrative 46.11M 46.53M 42.04M 45.05M 41.35M
Selling and marketing expenses - - - - -
Gross profit 112.02M 117.18M 94.45M 112.47M 101.66M
Reconciled depreciation 14.74M 11.59M 10.53M 10.10M 9.76M
Ebit 56.80M 76.77M 52.41M 67.42M 60.41M
Ebitda 82.69M 88.36M 76.59M 83.08M 70.16M
Depreciation and amortization 25.89M 11.59M 24.18M 15.65M 9.76M
Non operating income net other - 2.55M 13.10M 0.05M 1.94M
Operating income 56.80M 76.77M 52.41M 67.42M 60.31M
Other operating expenses 487.23M 419.78M 357.06M 414.54M 393.60M
Interest expense 5.78M 0.94M 1.63M 2.08M 2.04M
Tax provision 12.16M 15.27M 13.02M 13.65M 11.37M
Interest income 0.86M 0.20M 0.14M 0.05M 0.09M
Net interest income -4.92000M -0.74300M -1.49200M -2.03300M -1.94900M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 12.16M 15.27M 13.02M 13.65M 11.37M
Total revenue 553.14M 495.02M 422.97M 481.97M 453.91M
Total operating expenses 46.11M 41.94M 28.54M 45.05M 41.35M
Cost of revenue 441.12M 377.84M 328.52M 369.50M 352.25M
Total other income expense net -1.23000M -3.57700M 13.10M 3.48M 1.85M
Discontinued operations - - - - -
Net income from continuing ops 43.41M 57.92M 52.49M 57.26M 48.84M
Net income applicable to common shares 29.26M 40.83M 35.19M 40.04M 34.87M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 858.15M 749.43M 594.36M 560.85M 443.17M
Intangible assets 108.75M 86.38M 56.28M 52.59M 48.83M
Earning assets - - - - -
Other current assets 11.07M 4.18M 3.77M 5.79M 4.35M
Total liab 373.59M 296.98M 184.39M 181.39M 92.35M
Total stockholder equity 315.79M 295.61M 276.16M 240.26M 215.94M
Deferred long term liab - - - - 2.16M
Other current liab 37.41M 45.70M 59.75M 30.86M 38.49M
Common stock 0.15M 0.15M 0.15M 0.15M 0.15M
Capital stock 0.15M 0.15M 0.15M 0.15M 0.15M
Retained earnings 232.95M 223.57M 212.01M 184.35M 167.40M
Other liab 34.33M 21.73M 12.32M 10.21M 12.00M
Good will 494.10M 434.68M 345.65M 317.68M 293.52M
Other assets 1.63M 1.58M 14.05M 1.52M 1.43M
Cash 31.59M 28.57M 32.92M 23.55M 23.37M
Cash and equivalents - - - - -
Total current liabilities 85.49M 83.48M 93.49M 60.56M 41.95M
Current deferred revenue - - - - -
Net debt 263.74M 194.51M 78.07M 114.28M 16.47M
Short term debt 41.57M 31.30M 32.41M 27.21M 1.43M
Short long term debt 7.86M 0.83M 4.90M 0.73M 1.43M
Short long term debt total 295.34M 223.08M 110.99M 137.83M 39.84M
Other stockholder equity 78.69M 71.88M 63.99M 55.76M 112.55M
Property plant equipment 127.75M 119.41M 21.66M 22.09M 20.17M
Total current assets 111.27M 95.17M 87.64M 85.39M 79.21M
Long term investments 12.13M 12.21M - - -
Net tangible assets -287.06300M -225.45500M 6.57M 7.74M 7.54M
Short term investments - - - - -
Net receivables 68.61M 62.42M 50.95M 56.05M 51.49M
Long term debt 175.83M 117.59M 16.60M 50.36M 38.40M
Inventory - - - - -
Accounts payable 6.50M 6.47M 1.33M 2.49M 2.02M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - 1.57M 1.47M 1.44M 0.93M
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 4.00M -0.39500M - -66.09900M -64.15400M
Additional paid in capital - - - - -
Common stock total equity - 0.15M 0.15M 0.15M 0.15M
Preferred stock total equity - - - - -
Retained earnings total equity - 224.40M 212.01M 184.35M 167.40M
Treasury stock - -31.62800M -31.62800M -31.62800M -31.62800M
Accumulated amortization - - - - -
Non currrent assets other 4.15M 1.58M 1.54M 1.52M 1.43M
Deferred long term asset charges - - - - -
Non current assets total 746.89M 654.26M 506.73M 475.46M 363.95M
Capital lease obligations 111.64M 104.66M 89.50M 86.74M -
Long term debt total - 117.59M 16.60M 50.36M 38.40M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -81.26900M 0.43M -0.11100M -0.22100M -23.90900M
Change to liabilities -7.75500M 4.66M 16.92M -5.22900M 4.91M
Total cashflows from investing activities -81.26900M -124.13600M -51.20300M -37.99300M -23.90900M
Net borrowings 64.19M 93.10M -31.03700M 6.57M -20.04400M
Total cash from financing activities 25.76M 43.38M -39.42200M -24.27500M -47.66100M
Change to operating activities -3.39600M -6.96300M 10.31M -5.39700M -0.71000M
Net income 43.41M 57.92M 52.49M 57.26M 48.84M
Change in cash 3.03M -4.35100M 9.37M 0.18M 1.44M
Begin period cash flow 28.57M 32.92M 23.55M 23.37M 21.93M
End period cash flow 31.59M 28.57M 32.92M 23.55M 23.37M
Total cash from operating activities 58.54M 76.41M 100.00M 62.45M 73.00M
Issuance of capital stock - - - - -
Depreciation 14.74M 11.59M 10.53M 10.10M 9.76M
Other cashflows from investing activities - -114.73000M -43.45300M -27.58300M -16.71600M
Dividends paid -21.32100M -18.76500M -4.11000M -14.55500M 11.66M
Change to inventory - -4.65700M -12.42700M 4.21M -0.74200M
Change to account receivables -10.27900M -9.41700M 0.90M -6.37600M -3.43400M
Sale purchase of stock - 0.91M - 0.50M -0.26500M
Other cashflows from financing activities 233.88M 285.04M 209.72M 128.71M 87.05M
Change to netincome 33.07M 35.71M 14.42M 16.59M 13.68M
Capital expenditures 8.25M 8.20M 7.64M 10.19M 7.19M
Change receivables - -10.95500M 2.56M -8.87500M -4.52100M
Cash flows other operating - -0.63300M 3.07M -7.39200M 0.34M
Exchange rate changes - - - - -
Cash and cash equivalents changes - -4.35100M 9.37M 0.18M 1.44M
Change in working capital -21.43000M -11.72300M 23.64M -15.98200M 0.73M
Stock based compensation 7.26M 7.87M 7.92M 6.99M 5.94M
Other non cash items 10.24M 5.06M 5.67M -0.56000M 2.92M
Free cash flow 50.29M 68.20M 92.36M 52.26M 65.81M

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
USPH
US Physicalrapy Inc		 -0.58 0.72% 79.99 55.64 32.68 2.38 2.83 2.55 19.14
HCA
HCA Holdings Inc		 -7.49 1.37% 537.64 13.19 13.66 1.13 293.44 1.77 8.22
FSNUY
Fresenius SE & Co KGaA ADR		 0.05 0.36% 14.02 16.87 9.44 0.42 0.78 0.79 5.37
FSNUF
Fresenius SE & Co. KGaA		 - -% 54.35 16.76 9.62 0.42 0.79 0.78 5.31
JDHIY
JD Health International Inc		 - -% 9.08 62.50 35.97 0.30 2.32 0.16 3.90

Reports Covered

Stock Research & News

View All

Profile

U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The company operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. The company was founded in 1990 and is based in Houston, Texas.

US Physicalrapy Inc

1300 West Sam Houston Parkway South, Houston, TX, United States, 77042

Key Executives

Name Title Year Born
Mr. Christopher J. Reading Pres, CEO & Director 1964
Mr. Carey P. Hendrickson Chief Financial Officer 1962
Mr. Graham D. Reeve M.B.A., P.T. Chief Operating Officer - West 1964
Mr. Eric Joseph Williams Chief Operating Officer - East 1966
Mr. Jake Martinez Sr. VP of Fin. & Accounting 1979
Mr. Chadd Pence Sr. VP of Information Systems NA
Mr. Richard S. Binstein Exec. VP, Gen. Counsel & Sec. 1961
Ms. Jayne Fleck Pool ATC, PT, SCS Sr. VP & Chief Compliance Officer NA
Mr. Jason Anderson VP of HR NA
Mr. Jon C. Bates VP & Corp. Controller 1970

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.